An Ethical Argument for Ending Human Trials of Amyloid-Lowering Therapies in Alzheimer’s Disease-Reference-Cited by-同舟云学术

An Ethical Argument for Ending Human Trials of Amyloid-Lowering Therapies in Alzheimer’s Disease

Published:2022-10-05 Issue: Volume: Page:1-2
ISSN:2150-7740
Container-title:AJOB Neuroscience
language:en
Short-container-title:AJOB Neuroscience

Author:

Daly Timothy¹^ORCID,Herrup Karl²^ORCID,Espay Alberto J.³^ORCID

Affiliation:

1. UMR 8011 Sorbonne Université

2. University of Pittsburgh School of Medicine

3. University of Cincinnati

Publisher

Informa UK Limited

Subject

General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/21507740.2022.2129858

Reference9 articles.

1. CIOMS (Council for International Organizations of Medical Sciences). 2002. International ethical guidelines for biomedical research involving human subjects. https://cioms.ch/publications/product/international-ethical-guidelines-for-biomedical-research-involving-human-subjects-2/

2. Alzheimer's disease drug development pipeline: 2022

3. The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease

4. Acknowledgment of uncertainty: A fundamental means to ensure scientific and ethical validity in clinical research

5. Soluble Amyloid-β Consumption in Alzheimer’s Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical Issues Around Treatment-Induced Amyloid-Related Imaging Abnormalities in Alzheimer's Disease;Journal of Radiology Nursing;2024-09

2. Estimated effects of amyloid reduction on cognitive change: A Bayesian update across a range of priors;Alzheimer's & Dementia;2023-10-30

3. Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer’s Disease;Current Pharmaceutical Design;2023-10

4. Improving Clinical Trials of Antioxidants in Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-09-28

5. From Association to Intervention: The Alzheimer’s Disease-Associated Processes and Targets (ADAPT) Ontology;Journal of Alzheimer's Disease;2023-07-25